Choksi Laboratories Ltd vs Global Longlife Hospital And Research Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Choksi Laboratories Ltd is ₹ 207.75 as of 23 Oct 15:30 . The P/E Ratio of Choksi Laboratories Ltd changed from 84.7 on March 2022 to 36.7 on March 2026 . This represents a CAGR of -15.40% over 5 yearsThe P/E Ratio of Global Longlife Hospital and Research Ltd changed from 25.7 on March 2023 to 0 on March 2026 . This represents a CAGR of -100.00% over 4 years The Market Cap of Choksi Laboratories Ltd changed from ₹ 5.5 crore on March 2021 to ₹ 72.16 crore on March 2026 . This represents a CAGR of 53.58% over 6 yearsThe Market Cap of Global Longlife Hospital and Research Ltd changed from ₹ 47.02 crore on March 2023 to ₹ 14.34 crore on March 2026 . This represents a CAGR of -25.69% over 4 years The revenue of Choksi Laboratories Ltd for the Jun '26 is ₹ 12.08 crore as compare to the Mar '26 revenue of ₹ 12.88 crore. This represent the decline of -6.21% The revenue of Global Longlife Hospital and Research Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Choksi Laboratories Ltd for the Jun '26 is ₹ 3.3 crore as compare to the Mar '26 ebitda of ₹ 3.71 crore. This represent the decline of -11.05% The ebitda of Global Longlife Hospital and Research Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Choksi Laboratories Ltd changed from ₹ 0.42 crore to ₹ 0.58 crore over 9 quarters. This represents a CAGR of 15.43% The net profit of Global Longlife Hospital and Research Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Choksi Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Global Longlife Hospital and Research Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Choksi Laboratories Ltd

Choksi Laboratories Limited, incorporated on 29 January, 1993 provides contract testing and analytical services.
CLL is a group of research laboratories and consulting offices, offering analysis, calibration, pollution control, research and consultancy services to a broad spectrum of industries.
The Company analyses, for its clients, or as a regulatory requirement pharmaceuticals, food and agricultural products, construction materials, chemicals, Calibration and environment Monitoring services. The Company currently has facilities for analysis of over 1000 products and materials, with more being added every day.
It provides calibration of production & quality control equipment with traceability to national / international standards.
This means that the equipment are precise and therefore reducing the probability of end-product defects / rejects.

About Global Longlife Hospital and Research Ltd

Global Longlife Hospital and Research Limited was originally incorporated as 'Global Longlife Hospital and Research Private Limited' on January 20, 2012 with Registrar of Companies, Gujarat.
Subsequently, Company was converted into a Public Limited Company and , name of the Company was changed to 'Global Longlife Hospital and Research Limited' vide fresh Certificate of Incorporation dated August 31, 2021. The Company had acquired 1339 sq.mt. area land in the prime locality of Ahmedabad for starting hospital in March 2012.
The Hospital started journey in 2015 & determined to build an institution that offer to every human being, high quality healthcare at affordable prices in Ahmedabad. Mr. Dhruv Jani had also joined the hospital business with his father in July 2015.
The majority Equity shares of the Company were taken over by the present Promoters by acquiring the Equity shares from the Doctors and investors in the year 2017.

FAQs for the comparison of Choksi Laboratories Ltd and Global Longlife Hospital and Research Ltd

Which company has a larger market capitalization, Choksi Laboratories Ltd or Global Longlife Hospital and Research Ltd?

Market cap of Choksi Laboratories Ltd is 144 Cr while Market cap of Global Longlife Hospital and Research Ltd is 13 Cr

What are the key factors driving the stock performance of Choksi Laboratories Ltd and Global Longlife Hospital and Research Ltd?

The stock performance of Choksi Laboratories Ltd and Global Longlife Hospital and Research Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Choksi Laboratories Ltd and Global Longlife Hospital and Research Ltd?

As of October 25, 2026, the Choksi Laboratories Ltd stock price is INR ₹207.75. On the other hand, Global Longlife Hospital and Research Ltd stock price is INR ₹12.57.

How do dividend payouts of Choksi Laboratories Ltd and Global Longlife Hospital and Research Ltd compare?

To compare the dividend payouts of Choksi Laboratories Ltd and Global Longlife Hospital and Research Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.